click tracking
Swiss Life Sciences Database
Biotechgate Biotechgate Global Database › Global Trial › Global Log-in ›
Life Sciences Database
Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry

Results 1 - 20 out of 305 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16 »

Roche announces positive Phase III study results for Tecentriq plus Cotellic and Zelboraf in people with previously untreated BRAF V600 mutation-positive advanced melanoma

Read more ››
By: GlobenewsWire - 13 Dec 2019
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

Smart Decision to Launch Charitable Giving Program by Partnering with Notable Children’s Charity

Read more ››
By: GlobenewsWire - 12 Dec 2019

Roche’s fixed-dose subcutaneous combination of Perjeta and Herceptin comparable to intravenous formulations in people with HER2-positive breast cancer

Read more ››
By: GlobenewsWire - 12 Dec 2019
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

APHINITY six-year results strengthen evidence of clinical benefit with Roche’s Perjeta-based regimen

Read more ››
By: GlobenewsWire - 11 Dec 2019
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

Sanofi : Positive results presented from pivotal Phase 3 trial of sutimlimab in people with cold agglutinin disease

Read more ››
By: GlobenewsWire - 10 Dec 2019

Smart Decision Engages RedBand Systems for SaaS Development of Algorithmic CBD Consumer Platform

Read more ››
By: GlobenewsWire - 10 Dec 2019

Sanofi and Regeneron announce intent to restructure Antibody collaboration for Kevzara® (sarilumab) and Praluent® (alirocumab)

Read more ››
By: GlobenewsWire - 10 Dec 2019

Roche receives CE Mark for its Accu-Chek SugarView app

Read more ››
By: GlobenewsWire - 10 Dec 2019
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

Sanofi CEO unveils new strategy to drive innovation and growth

Read more ››
By: GlobenewsWire - 09 Dec 2019

Novo Nordisk A/S – Share repurchase programme

Read more ››
By: GlobenewsWire - 09 Dec 2019

Sanofi : Sanofi to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 Billion

Read more ››
By: GlobenewsWire - 09 Dec 2019

ObsEva Announces Positive Results from Uterine Fibroids Phase 3 Study (PRIMROSE 2) of Linzagolix

Read more ››
By: GlobenewsWire - 09 Dec 2019
Related companies:  ObsEva SA

Changes in the Board of Directors and the Corporate Executive Committee of Roche

Read more ››
By: GlobenewsWire - 09 Dec 2019
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc. to December 16, 2019

Read more ››
By: GlobenewsWire - 09 Dec 2019
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

New data demonstrate the continued clinical benefit of fixed-duration, chemotherapy-free Venclexta/Venclyxto-based treatments in chronic lymphocytic leukaemia

Read more ››
By: GlobenewsWire - 08 Dec 2019
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

ObsEva SA to Hold Conference Call to Discuss PRIMROSE 2 Trial Results on December 9, 2019

Read more ››
By: GlobenewsWire - 06 Dec 2019
Related companies:  ObsEva SA

Continued strong Cresemba® (isavuconazole) sales trigger second sales milestone this year from Pfizer to Basilea of USD 7 million

Read more ››
By: GlobenewsWire - 06 Dec 2019
Related companies:  Basilea Pharmaceutica Ltd

ARTIDIS Gains Strong Momentum in 2019, Raising CHF 8.8 Million in Seed Financing

BASEL, Switzerland, Dec. 5, 2019 /PRNewswire/ -- The funding will be used to advance the company's healthtech platform into a large multi-centre clinical study together with the University Hospital Tuebingen (Germany), University Hospital Barcelona (Spain), and Texas Medical Center (Houston,... Read more ››

By: PR Newswire Association LLC. - 05 Dec 2019

Idorsia and Mochida enter into a license agreement for the supply, co-development and co-marketing of daridorexant in Japan

Read more ››
By: GlobenewsWire - 05 Dec 2019
Related companies:  Idorsia Pharmaceuticals Ltd

Roche Holdings, Inc. Announces Pricing of its Debt Tender Offer and Increase to the Maximum Tender Amount

BASEL, Switzerland, Dec. 4, 2019 /PRNewswire/ -- Roche Holdings, Inc. (the "Offeror") announced today the pricing of its previously announced tender offer (the "Offer") to purchase for cash for a combined aggregate purchase price (exclusive of Accrued Interest (as defined herein))... Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16 »

Looking for companies outside of Switzerland?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

  • January 2020
    • San Francisco: East/West CEO
    • San Francisco: Biotech Showcase
    • San Francisco: 38th Annual J.P. Morgan Healthcare Conference
See Events »
Add an Event »

Latest company news

Roche announces positive Phase III study results for Tecentriq plus Cotellic and Zelboraf in people with previously untreated BRAF V600 mutation-positive advanced melanoma
13 Dec 2019 (GlobenewsWire)

Smart Decision to Launch Charitable Giving Program by Partnering with Notable Children’s Charity
12 Dec 2019 (GlobenewsWire)

Roche’s fixed-dose subcutaneous combination of Perjeta and Herceptin comparable to intravenous formulations in people with HER2-positive breast cancer
12 Dec 2019 (GlobenewsWire)

Biotechgate database

About Biotechgate
The Swiss Life Sciences Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com